BioSpace News Archive

Donna Strickland, 2018 Nobel Prize winner in Physics, addressed staff at The Optical Society (OSA) on Tuesday, 27 November

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced today that it has advanced the formation of a wholly owned subsidiary, BioShin™, a Shanghai based limited liability company, to develop and commercialize its late-stage migraine and neurology portfolio in China and other Asia-Pacific markets.

Varian (NYSE: VAR) today announced its Halcyon™ system has been approved by the China National Medical Product Administration (NMPA), which allows the company to market this new cancer treatment system in China.

Qualigen, Inc., a privately-owned company that provides novel diagnostic and therapeutic technologies for the treatment of cancer and infectious diseases, announced today the issuance of China Patent Number ZL 2017 30589986.5, which covers the design of Qualigen’s novel FastPack 2.0 Sample Port.

Eyenovia, Inc. (NASDAQ: EYEN) today announced that the full results of its Phase II PG21 study have been published in the article “Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose” in the November issue of the peer-review journal Clinical Ophthalmology

A recent article in Scientific Advances describes the utility of dTect™, EpiCypher’s latest technology to identify novel enzyme targets. These libraries are comprised of a diverse set of approximately 47 million degenerate peptide substrates to characterize lysine methyltransferase (KMT) activity and selectivity.

New Blockbuster Will Be Shown at 17 Children’s Hospitals and Health Facilities across the U.S. in Early December

Canada’s slow progress in reducing greenhouse gas emissions is having a significant impact on the physical and mental health of Canadians, suggests a new brief published today by the Lancet Countdown on Health and Climate Change.

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Phyto Animal Health has signed an agreement with national distribution leader Mr. Checkout to distribute its line of cannabidiol (CBD) hemp oil pet products to thousands of members of the Independent Pet Retailer Association.

The terms and conditions of the Tender Offer are more fully described in the Offer to Purchase, dated November 28, 2018 and the related Notice of Guaranteed Delivery